Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/45671, first published .
The Role of Telehealth in Promoting Equitable Abortion Access in the United States: Spatial Analysis

The Role of Telehealth in Promoting Equitable Abortion Access in the United States: Spatial Analysis

The Role of Telehealth in Promoting Equitable Abortion Access in the United States: Spatial Analysis

Journals

  1. Koenig L, Ko J, Valladares E, Coeytaux F, Wells E, Lyles C, Upadhyay U. Patient Acceptability of Telehealth Medication Abortion Care in the United States, 2021‒2022: A Cohort Study. American Journal of Public Health 2024:e1 View
  2. Upadhyay U, Koenig L, Meckstroth K, Ko J, Valladares E, Biggs M. Effectiveness and safety of telehealth medication abortion in the USA. Nature Medicine 2024;30(4):1191 View
  3. Espey E, Hailstorks T, Hofler L. Understanding the Impacts of the Supreme Court Case FDA v Alliance for Hippocratic Medicine. JAMA 2024;331(18):1529 View
  4. Morris N, Biggs M, Baba C, Seymour J, White K, Grossman D. Interest in and Support for Alternative Models of Medication Abortion Provision Among Patients Seeking Abortion in the United States. Women's Health Issues 2024;34(4):381 View
  5. Kim J, Cai Z, Chen M, Onyeka S, Ko J, Linos E. Telehealth Utilization and Associations in the United States During the Third Year of the COVID-19 Pandemic: Population-Based Survey Study in 2022. JMIR Public Health and Surveillance 2024;10:e51279 View
  6. Godfrey E, Zhang Y, Stulberg D. Primary Care’s Role in Prescribing Mail-Order Mifepristone. JAMA Internal Medicine 2024;184(8):859 View
  7. Grossman D, Raifman S, Morris N, Arena A, Bachrach L, Beaman J, Biggs M, Collins A, Hannum C, Ho S, Seibold-Simpson S, Sobota M, Tocce K, Schwarz E, Gold M. Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person Screening. JAMA Internal Medicine 2024;184(8):873 View
  8. Ralph L, Baba C, Biggs M, McNicholas C, Hagstrom Miller A, Grossman D. Comparison of No-Test Telehealth and In-Person Medication Abortion. JAMA 2024;332(11):898 View
  9. Chen J, Nijim S, Koelper N, Flynn A, Sonalkar S, Schreiber C, Roe A. Telemedicine Follow-up After Medication Management of Early Pregnancy Loss. Journal of Women's Health 2024;33(11):1449 View
  10. Barrow A, Cohen C, Serpico J, Goodman M, Grossman D, Raifman S, Upadhyay U. Brief of over 300 reproductive health researchers as Amici Curiae in FDA v. Alliance for Hippocratic Medicine. Perspectives on Sexual and Reproductive Health 2024 View
  11. Koenig L, Ko J, Upadhyay U. Virtual Clinic Telehealth Abortion Services in the United States One Year After Dobbs: Landscape Review. Journal of Medical Internet Research 2024;26:e50749 View
  12. Russell C, Manzo L, Walz T, Lu A, Harner H. Abortion access for U.S. active-duty servicewomen: A scoping review. Contraception 2024:110703 View
  13. Teal S. Excellent Performance of a Brief Self-Screening Tool for Medication Abortion Eligibility May Give Patients More Options. Obstetrics & Gynecology 2024;144(4):454 View
  14. Johnson D, Thompson T, Fix L, Jastaniah I, Grant M. Perceptions and experiences with two no-test direct-to-patient telehealth medication abortion regimens in the USA: an exploratory study with mifepristone and misoprostol and misoprostol-only regimens. BMJ Public Health 2024;2(2):e000808 View
  15. Fors S, Myers A, de Jong M, Sutton M, Vicente S. Navigating the Post-Dobbs Landscape: A Roadmap for Interstate Abortion Care. Journal of Science Policy & Governance 2024;25(1) View